Loading viewer...
investor_presentation
Format: PDF investor_presentation
Sequana Medical presents innovations in treating diuretic-resistant fluid overload across liver disease, malignant ascites, and heart failure. The company discusses the alfapump® system, currently under clinical investigation in the POSEIDON Study, and DSR® therapy in development. The presentation includes regulatory status, risk factors, and forward-looking statements regarding the company's therapeutic solutions.
conference
21 Pages
investor_presentation
8 Pages
Leslie's
Malaysian Pacific Industries Q1 FY21 Investors Briefing
investor_presentationinvestor_presentation
17 Pages
Malaysian Pacific Industries Berhad